Project Grant R21OD036471

Award Date 7/1/24
Completion Date 6/30/26
Dollars Obligated $294K
Funding Federal Agency
Office of the Director
Federal Grant Program
93.351
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98101, USA
Similar Awards
This Project Grant award from the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) provides $224,648 to the University of California, Irvine to conduct collaborative research on the shared genetic and cellular mechanisms underlying vertebrate limb and fin regeneration. The research aims to identify the core components of a "toolkit" for limb and fin regeneration by studying the axolotl, African lungfish, and grey bichir. Key objectives include: 1) Testing the...
This federal Project Grant award for $169,000.00, provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports the development of a single-cell reference atlas of axolotl embryogenesis. The overarching goal is to elucidate the fundamental biological processes required for limb regeneration, with the aim of informing future regenerative medicine strategies for human limb injuries...
This Project Grant award from the National Institutes of Health (NIH) Research Infrastructure Programs (CFDA 93.351) provides $844,954 to New York University School of Medicine to develop "Genomically Rewritten and Tailored Humanized Mouse Models for Various Organ Disorders." The project aims to leverage advanced DNA synthesis and editing technologies to create mouse models that accurately represent human disease conditions, enabling testing of cutting-edge therapies like gene...
This $1,174,440.00 federal Project Grant award, funded by the National Science Foundation (NSF) Division of Integrative Organismal Systems (CFDA 47.074 Biological Sciences), supports collaborative research to identify the shared genetic and cellular mechanisms underlying vertebrate limb and fin regeneration. The research team at Louisiana State University, the prime awardee, is using a comparative approach across three animal models - salamanders, lungfish, and Polypterus - to uncover the core...
This $619,681 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to The Leland Stanford Junior University (Stanford University) aims to develop innovative tools and conduct multi-omics research to better understand the genetic interactions underlying Alzheimer's disease (AD) pathogenesis. The key products to be delivered include: Combo-Seq/Tag, a toolkit combining precise installation of AD risk gene variants (Combo-Seq) with a multiplex protein tagging...
This three-year, $8.29 million project grant from the National Institutes of Health National Institute on Aging will support the development of full human gene replacement mouse models of Alzheimer's disease. Funded under the Aging Research program (CFDA 93.866), the Regents of the University of Minnesota will generate mouse lines with replacement of key Alzheimer's-related genes, including APP, PSEN1, PSEN2, MAPT, APOE, TREM2, MS4A, and INPP5D, with their full human orthologues. Control lines...
The National Institute of Child Health and Human Development (NICHD) awarded a $136,916 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to the Louisiana State University Agricultural Center to develop a computational model for predicting the morphology, patterning, and strength of regenerated bone in small animal models of limb regeneration. The project aims to create new tools to better evaluate the structural quality and function of regenerated bone,...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $1,140,000 in funding to the West Virginia University Research Corporation to conduct research on the regulation of body size and asexual reproduction by HOX genes and their role in animal regenerative abilities. The project aims to expand understanding of the functions of HOX genes, which are key to the evolutionary...
This NSF Biological Sciences (CFDA 47.074) award to Harvard University for $251,118 provides funding from October 1, 2024 to September 30, 2028 to conduct collaborative research on the shared genetic and cellular mechanisms of vertebrate limb and fin regeneration. The research will use a multi-layered comparative approach across salamanders, lungfish, and bichir fish to identify the key elements needed for limb and fin regeneration. Specific aims include: 1) testing if rapid activation of the...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $387,500.00 in funding to The Johns Hopkins University to conduct research on gene regulatory networks for hair cell regeneration. The goal is to understand the molecular mechanisms that regulate hair cell regeneration in zebrafish, with the aim of discovering therapies that could trigger a regenerative response in humans to repair...

ESTABLISHING ACOMYS AS A GENETIC PLATFORM FOR REGENERATION RESEARCH - PROJECT SUMMARY MANY OF THE MAJOR BIOLOGICAL DISCOVERIES OF THE 20TH CENTURY WERE MADE USING VERY FEW MODEL SPECIES. THEY WERE CHOSEN FOR HISTORICAL EXPERIMENTAL TRACTABILITY, RATHER THAN BIOLOGICAL ATTRIBUTES RELEVANT TO CRITICAL BIOLOGICAL QUESTIONS OR RELEVANCE TO PRESSING GLOBAL HEALTH ISSUES. YET THE ADVENT OF EFFICIENT SEQUENCING TECHNOLOGIES HAS MADE THE STUDY OF NEW ORGANISMS FEASIBLE. FOR EXAMPLE, THE STUDY OF CULTURED FIBROBLASTS FROM INCREDIBLY LARGE, LONG-LIVED AND CANCER FREE BOWHEAD WHALES HAS REVEALED EXTRAORDINARY ADAPTATIONS FOR EFFICIENT DNA REPAIR MECHANISMS IN THESE ANIMALS (1). YET BOWHEAD WHALES ARE NOT AT ALL EXPERIMENTALLY TRACTABLE OTHER THAN THROUGH CELL CULTURE. ACOMYS ARE AN EMERGING MODEL NON-FIBROTIC REGENERATION AND ARE THE ONLY KNOWN MAMMALIAN SPECIES WITH ANY SIGNIFICANT AND SYSTEMIC ADULT REGENERATIVE CAPACITY. AS A RODENT, ALBEIT WITH SOME UNUSUAL REPRODUCTIVE PHYSIOLOGY, THEY ARE READILY MAINTAINED IN THE LABORATORY, YET WE LACK TOOLS TO GENETICALLY EXPLOIT AND MANIPULATE THEIR NATURALLY SELECTED, ADVANTAGEOUS TRAITS. HISTORY HAS DEMONSTRATED THAT THE SUCCESS OF MODEL ORGANISMS IS SELF-PERPETUATING: AS THE COMMUNITY OF RESEARCHERS GROWS, NEW METHODOLOGIES AND RESOURCES ARE DEVELOPED AND SHARED, AND THE BODY OF SPECIFIC KNOWLEDGE AND ACCESS TO POWERFUL TOOLS TO MANIPULATE, OBSERVE AND EXPERIMENT UPON THESE MODEL ORGANISMS FURTHER LOWERS THE BAR TO ENTRY SO THAT THE CYCLE CAN REPEAT. HERE WE PROPOSE TO DEVELOP MULTIPLE GENETIC TOOLS INCLUDING INBRED LINES, ES CELLS FOR CHIMERIC AND ORGANOID ANALYSES, AND WHOLE ANIMAL TRANSGENESIS TO ESTABLISH ACOMYS AS EXPERIMENTALLY AND GENETICALLY TRACTABLE MODEL FOR MAMMALIAN NON-FIBROTIC REGENERATIVE HEALING AND HEALTHY AGING. THESE TECHNOLOGIES ARE FUNDAMENTAL TO DEFINE THE MECHANISMS DRIVING THE NATURALLY SELECTED REGENERATIVE CAPACITY IN THIS SPECIES, WHICH IN TURN ARE CERTAIN TO DRIVE THE CREATION OF NEW PRO-REGENERATIVE THERAPEUTICS FOR HUMAN REGENERATIVE MEDICINE.

Posted 6/24/24, 12:00 AM